Table 3.
Prevalence of Sickness Symptoms (N = 38).
Symptom | Symptom Measures (Cutoff Score) | Studies Using Symptom Measures | Symptom Prevalence |
---|---|---|---|
| |||
Fatigue | CIS (cutoff score of 35) | Goedendorp et al. (2013) | Severe fatigue 13% |
van Sandwijk et al. (2019) | Severe fatigue 33.3% | ||
MFI-20 (cutoff score varying between 12 and 15 among fatigue dimensions) | Chan et al. (2013) | 59% | |
Chan et al. (2016) | Physical fatigue 22% | ||
MTSOSD-59R | Du et al. (2021) | 54.92% | |
FSI (cutoff score of 3) | Rodrigue et al. (2011) | Severe fatigue 59% | |
POMS (N/R) | Tamura et al. (2018) | 5.9% | |
POSs-renal (cutoff score of 1) | Afshar et al. (2012) | 55% (30% moderate to severe) | |
Fatigue presence (yes/no) | Jordakieva et al. (2020) | 55.4% | |
Depressive symptoms | HADS (cutoff score of 5) | Vásquez et al. (2013) | 13.8% |
HADS (cutoff score of 7) | Barutcu Atas et al. (2021) | 44.3 | |
Gurkan et al. (2015) | 25% | ||
HADS (cutoff score of 8) | Müller et al. (2015) | 13.4% | |
Reber et al. (2016) | 16.2% | ||
van Sandwijk et al. (2019) | 16.7% | ||
Weng et al. (2013) | 6.8% | ||
Zhang et al. (2021) | 5.9% | ||
Zimmermann et al. (2016) | 37.6% | ||
HADS (cutoff score of 11) | Jana et al. (2014) | 8.57% | |
Klewitz et al. (2019) | 9.6% | ||
Scheel et al. (2018) | 16.7% | ||
BDI (cutoff score of 10) | Anvar-Abnavi and Bazargani (2010) | 75% | |
BDI (cutoff score of 11) | Brito et al. (2019) | 13.3% | |
BDI (N/R) | Látos et al. (2016) | 8.53% | |
BDI-PC (cutoff score of 4) | Goedendorp et al. (2013) | 13% | |
BDI-II (cutoff score: mild [>10], moderate [>15]) | Robiner et al. (2021) | BDI-II: mild 29% Moderate 14% |
|
MCMI-MD (base rate criteria of 75 or more) | Robiner et al. (2021) | 7% | |
SCL-90 | Alavi et al. (2009) | 39% | |
POSs-renal (cutoff score of 1) | Afshar et al. (2012) | 32% | |
BSI-18 (N/R) | Jordakieva et al. (2020) | 4.53% | |
DASS-21 (cutoff score of 10) | Lai et al. (2020) | 26.8% | |
POMS (cutoff t-score of 61) | Tamura et al. (2018) | 8.8% | |
MINI (N/A) | Vásquez et al. (2013) | 11.8% | |
PHQ-9 (cutoff score of 10) | Zhang et al. (2019) | 21.7% | |
Anxiety | HADS (cutoff score of 8) | Müller et al. (2015) | 25% |
Reber et al. (2016) | 24.3% | ||
Weng et al. (2013) | 17.9% | ||
Zhang et al. (2021) | 7.6% | ||
Zimmermann et al. (2016) | 50.4% | ||
HADS (cutoff score of 10) | Barutcu Atas et al. (2021) | 23.6% | |
Gurkan et al. (2015) | 26.3% | ||
HADS (cutoff score of 11) | Jana et al. (2014) | 8.57% | |
Klewitz et al. (2019) | 12.2% | ||
Scheel et al. (2018) | 63.9% | ||
BAI (cutoff score of 10) | Brito et al. (2019) | 20.3% | |
BAI (cutoff score of 16) | Anvar-Abnavi and Bazargani (2010) | 50% | |
SCL-90 (N/R) | Alavi et al. (2009) | 40.6% | |
POSs-renal (cutoff score of 1) | Afshar et al. (2012) | 36% | |
BSI-18 (N/R) | Jordakieva et al. (2020) | 4.03% | |
DASS-21 (cutoff score of 8) | Lai et al. (2020) | 41.1% | |
STAIS, STAIT (N/R) | Látos et al. (2016) | 4.26% | |
POMS (cutoff t-score of 61) | Tamura et al. (2018) | 4.4% | |
MINI (N/A) | Vásquez et al. (2013) | 15.1% |
Note: BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BDI-PC, Beck Depression Inventory-Primary Care; BSI-18, Brief Symptoms Inventory-18 items; CIS, Checklist Individual Strength; DASS-21, Depression, Anxiety, and Stress Scale-21 items; FSI, Fatigue Symptom Inventory; HADS, Hospital Anxiety and Depression Scale; MFI-20, Multidimensional Fatigue Inventory-20 items; MCMI-MD, Millon Clinical Multiaxial Inventory III-Major Depression Scale; MINI, Mini-International Neuropsychiatric Interview; MTSOSD-59R, Modified Transplant Symptom Occurrence and Distress Scale-59 items Revised; N/A, not applicable; N/R, not reported; PHQ-9, Patient Health Questionnaire-9 items; POMS, Profile of Mood States; POSs-renal, Patient Outcome Scale symptom score-renal; SCL-90, Symptom Checklist-90 items; STAIS, Spielberger’s State and Trait Anxiety Scale-State; STAIT, Spielberger’s State and Trait Anxiety Scale-Trait.